SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on 24-month HOPE-3 open-label extension data for deramiocel presented at the World Muscle Society congress; traders are highlighting delayed-start results suggesting slower upper-limb decline after patients switched to treatment. Optimism that the added evidence could support FDA approval is tempered by debate over the open-label analyses and the FDAs prior concerns about the statistical analysis plan.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Microns fiscal Q4 earnings report is the dominant focus, with traders watching guidance on memory pricing, supply tightness and AI-related demand. The community is bullish on strong results but divided over whether optimistic expectations are already priced in and whether a post-earnings selloff could follow; some also flag Netlists HBM patent action as a risk.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

Traders are linking DraftKings selloff mainly to competition from Kalshi and Polymarket and uncertainty over whether investment in its DKeX prediction-market platform can offset pressure on the sportsbook business; legal disputes over how prediction markets are regulated add to the concern. Bulls point to rising DKeX volume and sportsbook growth, while bears emphasize spending and margin risks, alongside scrutiny of DraftKings alleged use of AI to target promotions.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

A DEA administrative judges pause of the broader cannabis rescheduling case to consider adding a GAO report has delayed a closely watched Schedule III catalyst for MSOS and its U.S. cannabis holdings. Traders are split between calling the selloff an overreaction to a procedural delay and worrying that the pause could push rescheduling further out; the pause does not overturn the separate medical-marijuana rule.

Fair Isaac Corp. engages in the provision of decision management solutions. It operates through the Software and Scores segments. The Software segment includes pre-configured analytic and decision management solutions designed for a specific type of business need or process. The Scores segment focuses on business-to-business scoring solutions and services, business-to-consumer scoring solutions and services including myFICO solutions for consumers and associated professional services. The company was founded by Bill Fair and Earl Isaac in 1956 and is headquartered in San Jose, CA.

Fair Isaac Corp.

Fair, Isaac Corp.

FICO is under pressure after the FHFA moved to put VantageScore alongside FICO in mortgage pricing, with Rocket Mortgage also signaling a preference for VantageScore on eligible loans. Traders are debating whether this marks a lasting erosion of FICOs mortgage-scoring advantage and pricing power or an overreaction, with some selling on competition concerns and others viewing the sharp drop as a buying opportunity.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Positive Phase 3 results for Vandas HETLIOZ in delayed sleep-wake phase disorder are driving attention, with traders celebrating the study outcome and an after-hours jump. Some expect further momentum, while others question whether the rally will hold.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeings selection for the Navys next-generation F/A-XX fighter program, a contract valued at more than $20 billion, is drawing attention as traders weigh its boost to the defense backlog against concerns about Boeings execution and commercial-aircraft issues. Reactions are mixed: some see a meaningful win for the defense business, while others doubt the benefit until the company demonstrates stronger delivery and program performance.

Lighter is a decentralized trading platform built for unmatched security and scale. It’s the first exchange to offer verifiable order matching and liquidations while delivering best-in-class performance on par with traditional exchanges.

lighter

LIT is drawing attention after a sharp pullback following a strong rally, with traders split between buying the dip and taking profits amid concerns about upcoming token unlocks. Bullish traders point to Lighters Robinhood perps integration, rising trading activity, and revenue-funded token burns as support for the longer-term thesis.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

A judges pause in the broader cannabis rescheduling case has delayed the next step toward Schedule III, prompting concern about a setback as well as debate over whether it is only a temporary procedural delay. TRLV traders largely argue the company is cushioned by its medical-cannabis business, while some view the resulting sector selloff as a buying opportunity; the pause does not reverse the separate medical-cannabis rescheduling action.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances raised full-year revenue outlook, attributed to stronger demand for Amtagvi, is driving the sharp rally, with analyst upgrades adding to the enthusiasm. Traders largely view the move as validation of the commercial ramp and speculate about short covering, while others warn of profit-taking and possible dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

How Centene's Strong Cash Flow Is Reshaping Its Balance Sheet

Centene's robust cash flow is helping cut debt, with a lower debt-to-capital ratio and added liquidity reshaping its balance sheet.

Are Medical Stocks Lagging  Elevance Health, Inc. (ELV) This Year?

Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.

ELV or DHR: Which Is the Better Value Stock Right Now?

ELV vs. DHR: Which Stock Is the Better Value Option?

Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth

CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.

Can Centene's Medicare Advantage Strategy Unlock Better Margins?

CNC is set to reshape its Medicare Advantage business around dual-eligible members and a simpler footprint to drive margin recovery.

Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation

Elevance Health shares are jumping Thursday after the company reaffirmed its FY26 earnings guidance ahead of a series of investor meetings.read more...

UnitedHealth Reshapes Florida WellMed Operations With TPG Deal

UNH's TPG deal brings local support and investment to Florida WellMed clinics as Optum targets faster growth and stronger profitability.

UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?

UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.

Is UnitedHealth Finally Turning the Corner After a Tough 2025?

UNH is showing signs of recovery as medical costs improve, Optum gains momentum and 2026 earnings guidance rises.

Centene Stock Roars Back 117% in a Year: Is CNC Still a Buy?

CNC's 117% rally now has support from improving margins, firmer pricing and higher earnings expectations, while valuation remains below key peers.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

UNH, HUM, CNC Stocks Rally On Medicare Advantage Rate Surprise

Equity

Bullish Sentiment

Adding risk (buying more)

Trimming/taking profits

Rotating into safer assets

Staying the course, no changes

We&#39;re about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Stocktwits

We're about to enter Q4 - how are you positioning your portfolio for the rest of the year?

Microsoft Corp

Meta Platforms Inc

SELLAS Life Sciences Group Inc

Alphabet Inc Class A

CoreWeave Inc

SpaceX

Stocktwits Polls

Elevance Health reaffirmed its 2026 adjusted earnings guidance of at least $27.00 per diluted share in an SEC Regulation FD filing, while also providing an encouraging update on third-quarter performance. At the Wells Fargo Healthcare Conference, the company said Q3 adjusted EPS is tracking above the outlook provided following its second-quarter results, helped in part by favorable medical benefit expense trends. 
Elevance also maintained its target for at least $6 billion in operating cash flow in 2026 and reiterated its goal of achieving at least 12% adjusted EPS growth in 2027 based on 2026 results. The combination of stable earnings guidance, improving third-quarter trends and strong cash-flow expectations gave investors greater confidence in the company's recovery. 
The update was particularly significant as health insurers remain under pressure from rising medical costs and uncertainty surrounding Medicaid.  
$ELV

Top Stock Alerts

$ELV Called the top, drop and reversal at 350s. I shared this fractal back in JULY 2025.  
 
ITS STILL TRACKING.

Feed

News

Sentiment

Earnings

Fundamentals

Info

ELV Elevance Health Inc

Fundamentals

Latest ELV News